PlainRecalls
FDA Drug Moderate Class II Terminated

Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.

Reported: October 5, 2022 Initiated: September 15, 2022 #D-1545-2022

Product Description

Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
CIPLA
Units Affected
641,160 ampules
Distribution
Nationwide in the USA and Puerto Rico
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.. Recalled by CIPLA. Units affected: 641,160 ampules.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on October 5, 2022. Severity: Moderate. Recall number: D-1545-2022.